The efficacy and tolerability of daily cream containing N-butanoyl-l-glutathione (GSH-C4), beta-glycyrrhetinic, and azelaic acid for treatment in patients with mild to moderate rosacea was evaluated.
Epsolay is an investigational topical cream that utilizes the Company’s patented technology process to encapsulate benzoyl peroxide 5% within silica-based microcapsules.
Hypertension, dyslipidemia, and obesity were among the conditions investigators reviewed as being affected by the underlying inflammation associated with rosacea.
Skin redness and other symptoms associated with rosacea were found to improve with the use of a skincare regimen formulated for the treatment of centrofacial erythema.
An update to rosacea treatment guidelines provides a comprehensive summary of management options, including expert evaluations–based on the phenotypes of each patient–to serve as a guide for tailoring treatment and care.